Alltracel Pharmaceuticals Plc.

Pharmaceutical company reports 355% increase in revenue

Published in Lab Business Week, May 8th, 2005

Alltracel Pharmaceuticals Plc. (AP.L), a biopharmaceutical R&D company specializing in the medical device, oral care and cholesterol control markets, reported preliminary financial results for the year ended December 31, 2004.

Full year 2004 revenue grew to EUR4.6M, an increase of 355% over 2003 revenue of EUR1.0M, as a result of a combination of trade distribution gains of SEAL-ON branded products in the U.K. and U.S. markets, increased m*doc co-brand partner signings across the globe, and the successful launch of blotters into both the U.K. and U.S. markets in the fourth quarter.

Gross margins for the year were EUR1.7M averaging 38% over the course...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2005-05-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry